178 related articles for article (PubMed ID: 34311260)
1. Transcription factor NF-κB as target for SARS-CoV-2 drug discovery efforts using inflammation-based QSAR screening model.
Kanan T; Kanan D; Al Shardoub EJ; Durdagi S
J Mol Graph Model; 2021 Nov; 108():107968. PubMed ID: 34311260
[TBL] [Abstract][Full Text] [Related]
2. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
3. Chemical-informatics approach to COVID-19 drug discovery: Monte Carlo based QSAR, virtual screening and molecular docking study of some
Amin SA; Ghosh K; Gayen S; Jha T
J Biomol Struct Dyn; 2021 Aug; 39(13):4764-4773. PubMed ID: 32568618
[TBL] [Abstract][Full Text] [Related]
4. The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563673
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Nsp2 Contributes to Inflammation by Activating NF-κB.
Lacasse É; Gudimard L; Dubuc I; Gravel A; Allaeys I; Boilard É; Flamand L
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851549
[TBL] [Abstract][Full Text] [Related]
6. The NF-κB Transcriptional Footprint Is Essential for SARS-CoV-2 Replication.
Nilsson-Payant BE; Uhl S; Grimont A; Doane AS; Cohen P; Patel RS; Higgins CA; Acklin JA; Bram Y; Chandar V; Blanco-Melo D; Panis M; Lim JK; Elemento O; Schwartz RE; Rosenberg BR; Chandwani R; tenOever BR
J Virol; 2021 Nov; 95(23):e0125721. PubMed ID: 34523966
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide-based potential anti-inflammatory transcription inhibitors against nuclear factor NF-kappa-B p50 subunit (NF-κB p50): an integrated molecular and quantum mechanical approach.
Jain P; Sudandiradoss C
3 Biotech; 2023 Jan; 13(1):15. PubMed ID: 36540414
[TBL] [Abstract][Full Text] [Related]
8. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
[TBL] [Abstract][Full Text] [Related]
9. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Nsp14 protein associates with IMPDH2 and activates NF-κB signaling.
Li TW; Kenney AD; Park JG; Fiches GN; Liu H; Zhou D; Biswas A; Zhao W; Que J; Santoso N; Martinez-Sobrido L; Yount JS; Zhu J
Front Immunol; 2022; 13():1007089. PubMed ID: 36177032
[TBL] [Abstract][Full Text] [Related]
11. Novel tumor necrosis factor-α (TNF-α) inhibitors from small molecule library screening for their therapeutic activity profiles against rheumatoid arthritis using target-driven approaches and binary QSAR models.
Zaka M; Abbasi BH; Durdagi S
J Biomol Struct Dyn; 2019 Jun; 37(9):2464-2476. PubMed ID: 30047845
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal.
Proia E; Ragno A; Antonini L; Sabatino M; Mladenovič M; Capobianco R; Ragno R
J Comput Aided Mol Des; 2022 Jul; 36(7):483-505. PubMed ID: 35716228
[TBL] [Abstract][Full Text] [Related]
13. Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway.
Feng Y; Zhu B; Liu Y; Liu Y; Zhou G; Yang L; Liu L; Ren J; Hou Y; Yu H; Meng P; Jiang Y; Wang X
Phytomedicine; 2022 Jan; 95():153784. PubMed ID: 34785108
[TBL] [Abstract][Full Text] [Related]
14. The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients.
Zhou Q; Zhang L; Dong Y; Wang Y; Zhang B; Zhou S; Huang Q; Wu T; Chen G
Hypertens Res; 2024 Feb; 47(2):375-384. PubMed ID: 37872376
[TBL] [Abstract][Full Text] [Related]
15. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis.
Takada Y; Singh S; Aggarwal BB
J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.
Li W; Qiao J; You Q; Zong S; Peng Q; Liu Y; Hu S; Liu W; Li S; Shu X; Sun B
Front Immunol; 2021; 12():750969. PubMed ID: 34858407
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 ORF3a-Mediated NF-κB Activation Is Not Dependent on TRAF-Binding Sequence.
Busscher BM; Befekadu HB; Liu Z; Xiao TS
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005906
[TBL] [Abstract][Full Text] [Related]
18. Development of a deep learning-based quantitative structure-activity relationship model to identify potential inhibitors against the 3C-like protease of SARS-CoV-2.
Kumari M; Subbarao N
Future Med Chem; 2022 Nov; 14(21):1541-1559. PubMed ID: 36177879
[No Abstract] [Full Text] [Related]
19. Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study.
Kumar V; Kar S; De P; Roy K; Leszczynski J
SAR QSAR Environ Res; 2022 May; 33(5):357-386. PubMed ID: 35380087
[TBL] [Abstract][Full Text] [Related]
20. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
